Antimicrobial activity of NK cells to Trypanosoma cruzi infected human primary Keratinocytes

• Published in: PLoS neglected tropical diseases Vol. 18; no. 7; p. e0012255
• Main Authors: Kroh, Keshia, Barton, Jessica, Fehling, Helena, Lotter, Hanna, Volkmer, Beate, Greinert, Rüdiger, Mhamdi-Ghodbani, Mouna, Vanegas Ramirez, Andrea, Jacobs, Thomas, Gálvez, Rosa Isela
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 22.07.2024; Public Library of Science (PLoS)
• Subjects: Animals; Biology and Life Sciences; Causes of; Cells, Cultured; Chagas Disease - immunology; Chagas Disease - parasitology; Chagas' disease; Cytokines - metabolism; Development and progression; Health aspects; Humans; Immune response; Keratinocytes; Keratinocytes - immunology; Keratinocytes - parasitology; Killer cells; Killer Cells, Natural - immunology; Medicine and Health Sciences; Physiological aspects; Research and Analysis Methods; Skin; Trypanosoma cruzi; Trypanosoma cruzi - immunology; Trypanosoma cruzi - physiology; Brazil
• ISSN: 1935-2735; 1935-2727; 1935-2735
• DOI: 10.1371/journal.pntd.0012255

Infection with the protozoan parasite Trypanosoma cruzi is causative for Chagas disease, which is a highly neglected tropical disease prevalent in Latin America. Humans are primary infected through vectorial transmission by blood-sucking triatomine bugs. The parasite enters the human host through mucous membranes or small skin lesions. Since keratinocytes are the predominant cell type in the epidermis, they play a critical role in detecting disruptions in homeostasis and aiding in pathogen elimination by the immune system in the human skin as alternative antigen-presenting cells. Interestingly, keratinocytes also act as a reservoir for T. cruzi, as the skin has been identified as a major site of persistent infection in mice with chronic Chagas disease. Moreover, there are reports of the emergence of T. cruzi amastigote nests in the skin of immunocompromised individuals who are experiencing reactivation of Chagas disease. This observation implies that the skin may serve as a site for persistent parasite presence during chronic human infection too and underscores the significance of investigating the interactions between T. cruzi and skin cells. Consequently, the primary objective of this study was to establish and characterize the infection kinetics in human primary epidermal keratinocytes (hPEK). Our investigation focused on surface molecules that either facilitated or hindered the activation of natural killer (NK) cells, which play a crucial role in controlling the infection. To simulate the in vivo situation in humans, an autologous co-culture model was developed to examine the interactions between T. cruzi infected keratinocytes and NK cells. We evaluated the degranulation, cytokine production, and cytotoxicity of NK cells in response to the infected keratinocytes. We observed a strong activation of NK cells by infected keratinocytes, despite minimal alterations in the expression of activating or inhibitory ligands on NK cell receptors. However, stimulation with recombinant interferon-gamma (IFN-γ), a cytokine known to be present in significant quantities during chronic T. cruzi infections in the host, resulted in a substantial upregulation of these ligands on primary keratinocytes. Overall, our findings suggest the crucial role of NK cells in controlling acute T. cruzi infection in the upper layer of the skin and shed light on keratinocytes as potential initial targets of infection.